: Quarterly results  In Q3/2018, the Company and its subsidiary recorded total sales of Baht 1,205 million, a decrease of 20% YoY, mainly due to the drop in export CMG, domestic CMG, and domestic branded sales

: o The impact from COVID-19 outbreak which caused a drop in number of general clients, especially a significant decrease in outbound patients due to the inability of travelling for their medical

restrictions and faced 100% drop in foreign tourist numbers. Likewise, the export sector has been affected by declining demand from trading-partner countries. In addition, the purchasing power of consumers is

. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 June (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease) For Three Months Period Ended 30

effective since 1 January 2019. Table 1 : Sales Revenue by Product Line for the Three Months period ended 30 September (3M YoY) Sales by geography Consolidated financial statements Change Increase/(Decrease

decrease due to drop in sales revenue as provided in Section 1 above. Please be informed accordingly. Yours sincerely, Mr. Hamidi Bin Maulod Chief Executive Officer

”)/(“LATMI”) INGRS registered LATMI of Baht 64.44 million for the 3-months period ended 30 April 2020 as compared to the same period last year with PATMI Baht 6.53 million. Explanation for such decrease due to

33.31 million, other income decreased Bath 45.13 million because profit sharing from investment in BBF decreased at the amount of Baht 46.65 million due to crude palm oil price drop resulting in decrease

amounting to Baht 38.90 million, but there was no sale of investment in Q1 2018. Due to the offset between a decrease in financial cost and a decline in revenues, the net profit remained flat. In Q1 2018

. Explanation for such decrease due to drop in sales as provided in Section 1 above. Please be informed accordingly. Yours sincerely, Mr. Hamidi Bin Maulod Chief Executive Officer